NCD Risk Factor Collaboration (NCD-RisC) (Kim Overvad, Marzieh Katibeh;members 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants ', Lancet, vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 The Lancet LANCET r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname NCD Risk Factor Collaboration (NCD-RisC) & O'Neill, T W 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants ', Lancet (London, England), vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante The Lancet 398 (2021) 10304 The Lancet, 398(10304), 957-980 The Lancet HIV, 398(10304), 957. Lancet Publishing Group Zaguán. Repositorio Digital de la Universidad de Zaragoza Web of Science Repositório Institucional da UNESP Universidade Estadual Paulista (UNESP) instacron:UNESP The Lancet, Elsevier, 2021, 398 (10304), pp.957-980. ⟨10.1016/S0140-6736(21)01330-1⟩ The Lancet Digital Health The Lancet Digital Health, Elsevier, 2021, 398 (10304), pp.957-980. ⟨10.1016/s0140-6736(21)01330-1⟩ NCD Risk Factor Collaboration (NCD-RisC) 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants ', The Lancet, vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 The Lancet, 398(10304), 957-980. Elsevier Ltd. The Lancet, 2021, 398 (10304), pp.957-980. ⟨10.1016/S0140-6736(21)01330-1⟩ Zhou, B, Carrillo-Larco, R M, Danaei, G, Riley, L M, Paciorek, C J, Stevens, G A, Gregg, E W, Bennett, J E, Solomon, B, Singleton, R K, Sophiea, M K, Iurilli, M LC, Lhoste, V PF, Cowan, M J, Savin, S, Woodward, M, Balanova, Y, Cifkova, R, Damasceno, A, Elliott, P, Farzadfar, F, Afzal, S, Allin, K, Andersen, L B, Bjerregaard, P, Bojesen, S E, Christensen, K, Dantoft, T M, Eliasen, M, Eriksen, L, Frikke-Schmidt, R, Giwercman, A, Halkjær, J, Jørgensen, T, Kristensen, P L, Lind, L, Linneberg, A, Mårild, S B, Møllehave, L T, Nguyen, Q V, Nordestgaard, B G, Overvad, K, Schnohr, P, Sobngwi, E, Sørensen, T IA, Tjønneland, A, Toft, U, Tolstrup, J S, Wang, Y W, Yang, Y & NCD Risk Factor Collaboration (NCD-RisC) 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants ', The Lancet, vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 The Lancet, 398(10304), 957-980. Elsevier Limited NCD Risk Factor Collaboration (NCD-RisC) 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants ', Lancet, vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 The lancet, 398(10304):957-980 The Lancet, 398(10304), 957-980. ELSEVIER SCIENCE INC
The New England Journal of Medicine, 376, 16, pp. 1527-1539 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2017, 376 (16), pp.1527-1539. ⟨10.1056/NEJMoa1701488⟩ New England Journal of Medicine, 376(16), 1527-1539. MASSACHUSETTS MEDICAL SOCIETY New England Journal of Medicine, 376(16), 1527. Massachussetts Medical Society The New England Journal of Medicine, 376, 1527-1539 Department of Medicine Publications Ridker, P M, Revkin, J, Amarenco, P, Brunell, R, Curto, M, Civeira, F, Flather, M, Glynn, R J, Gregoire, J, Jukema, J W, Karpov, Y, Kastelein, J J P, Koenig, W, Lorenzatti, A, Manga, P, Masiukiewicz, U, Miller, M, Mosterd, A, Murin, J, Nicolau, J C, Nissen, S, Ponikowski, P, Santos, R D, Schwartz, P F, Soran, H, White, H, Wright, R S, Vrablik, M, Yunis, C, Shear, C L, Tardif, J-C, SPIRE Cardiovascular Outcome Investigators & Michael Jepsen, J 2017, ' Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients ', The New England Journal of Medicine, vol. 376, no. 16, pp. 1527-1539 . https://doi.org/10.1056/NEJMoa1701488 New England Journal of Medicine, 376(16), 1527-1539 Zaguán. Repositorio Digital de la Universidad de Zaragoza instname New England journal of medicine, 376(16), 1527-1539. Massachussetts Medical Society